Low Dose Atropine for Symptomatic Vitreous Floaters

计划入组 200 人 · 首次发布于 2023 年 12 月 18 日

Low-Dose Atropine for Treatment of Myopia

计划入组 200 人 · 首次发布于 2017 年 11 月 7 日

Adverse Events Related to Low Dose Atropine

计划入组 148 人 · 首次发布于 2023 年 1 月 13 日

low dose interleukin-2

Atropine(Atnaa, Atropen, Busulfex, Donnatal, Duodote, Enlon-plus, Isopto Atropine, Lomotil, Minims Atropine Sulphate, Motofen, Phenohytro, Ryjunea, Atropine sulfate FGK)

C₁₇H₂₃NO₃

low dose human recombinant interleukin-2

UNIT DOSE SERVICES

United States

Precision Dose, Inc.

United States

Dose Biosystems Inc.

Canada

FDA Rejection of Low-Dose Atropine Sparks Industry Petition and Calls for Myopia Reclassification

Eyenovia's Phase 3 CHAPERONE Study Fails to Meet Primary Endpoint in Pediatric Myopia

FDA to Convene Advisory Committee to Review Sydnexis's SYD-101 for Pediatric Progressive Myopia